Clinical and laboratory experience with clindamycin.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D002908:Chronic Disease; D006027:Glycosides / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption; D008034:Lincomycin / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D012008:Recurrence; D013203:Staphylococcal Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D006027:Glycosides; D011759:Pyrrolidines; D008034:Lincomycin